Business Context and Reporting Period
This Form 8-K filing by Shuttle Pharmaceuticals Holdings, Inc. (SHPH) covers the event date of August 27, 2024. The report addresses the company's compliance status with the Nasdaq Stock Market listing requirements.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The only quantitative metric provided relates to the company's stock price performance:
- Stock Price Compliance: The company traded above $1.00 per share for 10 consecutive trading days from August 13, 2024, to August 26, 2024.
Material Changes
The primary material change reported is the regaining of compliance with Nasdaq Listing Rule 5550(a)(2), the Minimum Bid Price Requirement. Prior to this period, the company was non-compliant with this rule. The compliance was achieved through sustained trading activity above the $1.00 threshold.
Outlook, Risks, and Management Commentary
Management confirmed via a press release issued on August 28, 2024, that the company has successfully regained compliance. No forward-looking guidance, new risks, contingencies, or unusual items were disclosed in this specific filing. The filing serves primarily as a notification of regulatory status restoration.
Investor Verification Checklist
- Verify the current trading price of SHPH to ensure it remains above the $1.00 minimum bid price requirement.
- Review the attached press release (Exhibit 99.1) for any additional context regarding the stock price movement.
- Monitor future filings for any potential relapse into non-compliance if the stock price falls below $1.00 again.